BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10469901)

  • 1. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.
    Krögel I; Bodmeier R
    J Control Release; 1999 Aug; 61(1-2):43-50. PubMed ID: 10469901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ; Ryu SG; Cui JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery.
    Mehuys E; Vervaet C; Remon JP
    J Control Release; 2004 Feb; 94(2-3):273-80. PubMed ID: 14744479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
    McConville JT; Ross AC; Florence AJ; Stevens HN
    Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion.
    Ross AC; MacRae RJ; Walther M; Stevens HN
    J Pharm Pharmacol; 2000 Aug; 52(8):903-9. PubMed ID: 11007060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate.
    Bettini R; Catellani PL; Santi P; Massimo G; Peppas NA; Colombo P
    J Control Release; 2001 Feb; 70(3):383-91. PubMed ID: 11182208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets.
    Heng PW; Chan LW; Easterbrook MG; Li X
    J Control Release; 2001 Sep; 76(1-2):39-49. PubMed ID: 11532311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug.
    Colombo P; Bettini R; Peppas NA
    J Control Release; 1999 Aug; 61(1-2):83-91. PubMed ID: 10469905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.
    Takka S; Rajbhandari S; Sakr A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):75-82. PubMed ID: 11438426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.